The project led by Rallys Pliauzer of Grupo Bagó and Osman Khalid Waheed of Ferozons marked a historic agreement between both nations, positioning the company as a symbol of international cooperation. Pliauzer, director of Grupo Bagó and founder of BF Biosciences, emphasized that this milestone strengthens biotechnological development and reinforces the commitment to innovation and leadership in the sector.
"This milestone allows us to strengthen biotechnological development and reinforces our commitment to innovation and leadership in the sector," highlighted Pliauzer, director of Grupo Bagó and founder of BF Biosciences. "Moreover, it drives us to continue offering high-quality products to improve the health and well-being of people and to contribute significantly to the advancement of science and sustainable development both in the local market and in the Asia region," he added.
At the stock market launch ceremony, Pliauzer, Waheed (director of BF Biosciences Limited), Farhan Rafiq (COO of BF Biosciences Limited), and Sebastián Sayús, Argentine ambassador in Pakistan, were present. The IPO of BF Biosciences Limited will facilitate the arrival of investors interested in supporting the development of the industry in Pakistan and seizing growth opportunities in the biotechnological sector.
The funds raised will be used to expand production capacity, research and develop new products, and improve technological infrastructure. Since 2002, Bagó and Ferozons have been business partners, and after signing an exclusive distribution agreement, they have worked together in production and distribution in the region.
BF Biosciences Limited, a joint venture between Grupo Bagó and Ferozons Biociences, became the first company to manufacture biotechnological products in Pakistan. Its Initial Public Offering (IPO) on the country's stock exchange raised 1,930 million Pakistani rupees, equivalent to nearly USD 7 million.
The company has managed to expand its international presence to more than 50 countries and has made significant industrial investments in recent years, such as the installation of a new lyophilizer capable of producing 90,000 units daily. The rapid expansion of BF Biosciences has been crucial in the development of the biotechnological industry and in trade relations between Argentina and Pakistan.